Literature DB >> 29433807

Deep brain stimulation for tardive syndromes: Systematic review and meta-analysis.

Antonella Macerollo1, Günther Deuschl2.   

Abstract

Among the broad entity of tardive syndromes, tardive dystonia and classical tardive dyskinesia sometimes require advanced treatments like deep brain stimulation of the globus pallidus internum (Gpi-DBS) or the subthalamic nucleus (STN-DBS). This systematic review has analyzed the currently available literature reporting cases with either tardive dystonia or dyskinesia treated with DBS. The key words for the literature search included all tardive syndromes and "deep brain stimulation." Thirty-four level VI studies and one level II study with 117 patients were included. Level I studies were not identified. Only four of the patients had tardive dyskinesia. All the others had tardive dystonia. The majority had Gpi-DBS (n = 109). Patients had a mean age of 47.4 (± SD 14.7) years. The duration of follow-up was 25.6 months ± 26.2. The Abnormal Involuntary Movement Scale was reported in 51 patients with an improvement of 62 ± 15% and the Burke-Fahn-Marsden scale was reported in 67 cases with an improvement of 76 ± 21%. Reported adverse events were surgery-related in 7 patients, stimulation-induced in 12, and psychiatric in 3 patients. These reports thus suggest favorable effects of DBS and it seems to be relatively safe. DBS can be considered for patients with severe, medication-resistant symptoms. Controlled and randomized studies with blinded outcomes are needed.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; GPi; STN; Tardive dyskinesia; Tardive dystonia; Tardive syndromes

Mesh:

Substances:

Year:  2018        PMID: 29433807     DOI: 10.1016/j.jns.2018.02.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Deep brain stimulation in Fragile X syndrome with tardive dystonia.

Authors:  Francesco Bove; Carla Piano; Anna Rita Bentivoglio; Pietro Chiurazzi; Tommaso Tufo
Journal:  Neurol Sci       Date:  2021-02-12       Impact factor: 3.307

Review 2.  Drug-induced movement disorders.

Authors:  Stephen R Duma; Victor Sc Fung
Journal:  Aust Prescr       Date:  2019-04-01

3.  Tardive Dyskinesia: Spotlight on Current Approaches to Treatment.

Authors:  Sarah M Debrey; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25

Review 4.  Medical and Surgical Treatment for Medication-Induced Tremor: Case Report and Systematic Review.

Authors:  Wardell E Amerika; Saskia van der Gaag; Arne Mosch; Niels A van der Gaag; Carel F E Hoffmann; Rodi Zutt; Johan Marinus; Maria Fiorella Contarino
Journal:  Mov Disord Clin Pract       Date:  2022-05-24

Review 5.  VMAT2 Inhibitors in Neuropsychiatric Disorders.

Authors:  Arjun Tarakad; Joohi Jimenez-Shahed
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

6.  Resolution of tardive tremor after bilateral subthalamic nucleus deep brain stimulation placement.

Authors:  Samir Kashyap; Rita Ceponiene; Paras Savla; Jacob Bernstein; Hammad Ghanchi; Ajay Ananda
Journal:  Surg Neurol Int       Date:  2020-12-16

7.  Neurobiological mechanisms associated with antipsychotic drug-induced dystonia.

Authors:  Anton Jm Loonen; Svetlana A Ivanova
Journal:  J Psychopharmacol       Date:  2020-09-09       Impact factor: 4.153

Review 8.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.